Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

NCT03710889 is registered in ClinicalTrials.gov with Radius Health, Inc. as lead sponsor.

NCT NCT03710889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03710889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Lead sponsor
Radius Health, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 20, 2018
Completion date
July 15, 2020
Enrollment
23 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, osteoporosis fracture, osteoporosis localized to spine, osteoporosis of vertebrae, osteoporosis risk, osteoporosis senile, osteoporosis vertebral, osteoporosis, age-related, osteoporosis, postmenopausal